NCITA News/Press Releases - NCITA

<img decoding="async" width="1209" height="1217" src="https://ncita.org.uk/wp-content/uploads/2022/09/biopsy-grid-cropped.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" srcset="https://ncita.org.uk/wp-content/uploads/2022/09/biopsy-grid-cropped.jpg 1209w, https://ncita.org.uk/wp-content/uploads/2022/09/biopsy-grid-cropped-298x300.jpg 298w, https://ncita.org.uk/wp-content/uploads/2022/09/biopsy-grid-cropped-1017x1024.jpg 1017w, https://ncita.org.uk/wp-content/uploads/2022/09/biopsy-grid-cropped-150x150.jpg 150w, https://ncita.org.uk/wp-content/uploads/2022/09/biopsy-grid-cropped-768x773.jpg 768w, https://ncita.org.uk/wp-content/uploads/2022/09/biopsy-grid-cropped-144x144.jpg 144w" sizes="(max-width: 1209px) 100vw, 1209px" />

News Release: Unique Clinical Imaging Dataset Released for Artificial Intelligence Research to Accelerate Diagnosis of Prostate Cancer

The National Cancer Imaging Translational Accelerator (NCITA) in partnership with the ReIMAGINE Consortium have announced the release of a unique […]

September 23 2022

<img loading="lazy" decoding="async" width="1280" height="720" src="https://ncita.org.uk/wp-content/uploads/2022/08/images_large_radiol.212536.va_-e1659530745115.jpeg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" srcset="https://ncita.org.uk/wp-content/uploads/2022/08/images_large_radiol.212536.va_-e1659530745115.jpeg 1280w, https://ncita.org.uk/wp-content/uploads/2022/08/images_large_radiol.212536.va_-e1659530745115-300x169.jpeg 300w, https://ncita.org.uk/wp-content/uploads/2022/08/images_large_radiol.212536.va_-e1659530745115-1024x576.jpeg 1024w, https://ncita.org.uk/wp-content/uploads/2022/08/images_large_radiol.212536.va_-e1659530745115-768x432.jpeg 768w" sizes="(max-width: 1280px) 100vw, 1280px" />

News Release: New prostate cancer test prevents 90% of unnecessary prostate biopsies

A new type of MRI scan could help doctors diagnose prostate cancer more accurately – and spare thousands of men […]

MRI and PET CT scan showing imaging habitats in ovarian tumour (Credit Evis Sala University of Cambridge)

<img loading="lazy" decoding="async" width="465" height="289" src="https://ncita.org.uk/wp-content/uploads/2020/03/MRI-and-PET-CT-scan-showing-imaging-habitats-in-ovarian-tumour-Credit-Evis-Sala-University-of-Cambridge-005.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="MRI and PET CT scan showing imaging habitats in ovarian tumour (Credit Evis Sala University of Cambridge)" srcset="https://ncita.org.uk/wp-content/uploads/2020/03/MRI-and-PET-CT-scan-showing-imaging-habitats-in-ovarian-tumour-Credit-Evis-Sala-University-of-Cambridge-005.jpg 465w, https://ncita.org.uk/wp-content/uploads/2020/03/MRI-and-PET-CT-scan-showing-imaging-habitats-in-ovarian-tumour-Credit-Evis-Sala-University-of-Cambridge-005-300x186.jpg 300w" sizes="(max-width: 465px) 100vw, 465px" />

NCITA News Release 26th March 2020 – Integrating Cancer Imaging Biomarker Clinical Research Across the UK

The UK National Cancer Imaging Translational Accelerator (NCITA) establishes infrastructure for validation and adoption of cancer imaging biomarkers as decision-making […]